Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience

Table 2 Treatment regimens prior to vinflunine (ITT-population: n = 77)

Patients might have had more than one previous therapy. Therapies were listed if > 3 % of the patients were treated with the regimen. Other regimens include (with decreasing frequency): methotrexate/vinblastine/doxorubicin/cisplatin (conventional and dose dense), docetaxel, cisplatin/paclitaxel, carboplatin/paclitaxel

ISSN: 1471-2407